oxbt.co.uk oxbt.co.uk

OXBT.CO.UK

Oxford BioTherapeutics

Oxford BioTherapeutics is an international biotechnology company focused on developing innovative antibody drug conjugates (ADCs) to treat cancer. This new treatment approach combines a number of technologies to target cancer cells with potent cell-killing agents. Our OGAP target discovery system - the largest of its type in the world - 'unlocks' the power of ADCs by providing a unique range of validated, novel targets identified from a wide range of cancer types.

http://oxbt.co.uk/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR OXBT.CO.UK

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.4 out of 5 with 8 reviews
5 star
0
4 star
5
3 star
2
2 star
0
1 star
1

Hey there! Start your review of oxbt.co.uk

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

CONTACTS AT OXBT.CO.UK

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Oxford BioTherapeutics | oxbt.co.uk Reviews
<META>
DESCRIPTION
Oxford BioTherapeutics is an international biotechnology company focused on developing innovative antibody drug conjugates (ADCs) to treat cancer. This new treatment approach combines a number of technologies to target cancer cells with potent cell-killing agents. Our OGAP target discovery system - the largest of its type in the world - 'unlocks' the power of ADCs by providing a unique range of validated, novel targets identified from a wide range of cancer types.
<META>
KEYWORDS
1 about us
2 management
3 board of directors
4 investors
5 careers uk
6 careers usa
7 technologies
8 antibody development
9 cancer therapy development
10 pipeline
CONTENT
Page content here
KEYWORDS ON
PAGE
about us,management,board of directors,investors,careers uk,careers usa,technologies,antibody development,cancer therapy development,pipeline,lead programs,news,press releases,news archives,precision,cancer,therapy,latest news,global headquarters,sitemap
SERVER
Apache
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Oxford BioTherapeutics | oxbt.co.uk Reviews

https://oxbt.co.uk

Oxford BioTherapeutics is an international biotechnology company focused on developing innovative antibody drug conjugates (ADCs) to treat cancer. This new treatment approach combines a number of technologies to target cancer cells with potent cell-killing agents. Our OGAP target discovery system - the largest of its type in the world - 'unlocks' the power of ADCs by providing a unique range of validated, novel targets identified from a wide range of cancer types.

INTERNAL PAGES

oxbt.co.uk oxbt.co.uk
1

Oxford BioTherapeutics | About Us

http://oxbt.co.uk/about-us

OGAP – Cancer Targeting. Antibody ‘arming’. Through our collaborations with other leading companies in the field, such as Seattle Genetics, ImmunoGen, Medarex and Amgen, we can use the optimal combination of technologies to develop successful ADCs. First in-house clinical candidate designated. Collaboration with Boehringer Ingelheim. 1BN R&D investment collaboration with Menarini. Cancer toxin collaboration with Seattle Genetics. Enhanced antibody partnership with BioWa. Antibody partnership with Amgen.

2

Oxford BioTherapeutics | News

http://oxbt.co.uk/news

OGAP – Cancer Targeting. Antibody ‘arming’. Oxford BioTherapeutics provides regular updates of our R&D, scientific and corporate progress through regular conference presentations, scientific journal publications and press releases. For more information please contact us. The OBT / Menarini partnership has been cited in the September issue of Nature’s BioPharma Dealmakers as the second most significant antibody and ADC technology platform deals over $100m total deal value between Jan 2009 July 2014. Oxfor...

3

Oxford BioTherapeutics | Pipeline

http://oxbt.co.uk/pipeline

OGAP – Cancer Targeting. Antibody ‘arming’. Strong portfolio of novel antibody-based cancer therapies. Oxford BioTherapeutics is focused on developing innovative antibody-based cancer treatments, based on a range of proprietary technologies. OBT357/MEN1112 – AML. OX002/MEN1309 – TNBC. OX003 – SCLC / NSCLC. AML = acute myeloid leukemia. TNBC = triple negative breast cancer. SCLC = small cell lung cancer. NSCLC = non-small cell lung cancer. 44 (0) 1235 861770. San Jose, CA 95138.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

3

OTHER SITES

oxbspeaking.co.kr oxbspeaking.co.kr

:: 전화/화상영어에 오신 것을 환영합니다 ::

oxbspeaking.com oxbspeaking.com

옥스비스피킹 홈페이지에 오신 여러분을 환영합니다

대표이사 양동인 ㅣ 서울특별시 강남구 테헤란로5길 11 옥스비 에듀타운 ㅣ 사업자등록번호 220-87-35161. 통신판매업신고번호 2008-서울강남-2843호 ㅣ 대표전화 1566-0511 ㅣ FAX 02)6217-0515.

oxbsscholarship.com oxbsscholarship.com

Theta Chi Scholarship

Theta Chi Beta Sigma. Hello and welcome to the Theta Chi Beta Sigma Scholarship Website. This website has been designed to streamline Theta Chi scholarship. Simply log in to the website and log any hours that you have spent studying in the library, in your room, or anywhere else on campus. In addition to this, you may view the amount of hours you have submitted over the course of the entire semester, and on a week to week basis. If you are a brother of Beta Sigma, then click on this link.

oxbstudio.com oxbstudio.com

oxbstudio-architecture

OXBSTUDIO is a multi-disciplinary architectural firm specializing in high-end custom residential projects. We look to develop a unique method of design for each client, whose desires, needs, beliefs and building sites are different from any other. We balance the client’s requirements with functionality, constructibility and the use of diverse materials to create spaces and forms which are stimulating, distinctive and appropriate. C) 2015 - Artcore Creative Architecture WordPress Theme.

oxbsz.leteya.pw oxbsz.leteya.pw

leteya.pw

oxbt.co.uk oxbt.co.uk

Oxford BioTherapeutics

OGAP – Cancer Targeting. Antibody ‘arming’. Our novel cancer therapies combine a number of precision technologies. We are focused on developing antibody-drug conjugates to treat a range of cancers. Our antibody-based therapeutics target a variety of difficult to treat cancers. Targeting Unmet Needs in Cancer with Antibody-Drug Conjugates. Targeting Unmet Needs in Cancer with Antibody-Drug Conjugates. We are developing precision cancer therapies. Our therapies incorporate leading technologies. Oxford BioT...

oxbt.com oxbt.com

Oxford BioTherapeutics

OGAP – Cancer Targeting. Antibody ‘arming’. Our novel cancer therapies combine a number of precision technologies. We are focused on developing antibody-drug conjugates to treat a range of cancers. Our antibody-based therapeutics target a variety of difficult to treat cancers. Targeting Unmet Needs in Cancer with Antibody-Drug Conjugates. Targeting Unmet Needs in Cancer with Antibody-Drug Conjugates. We are developing precision cancer therapies. Our therapies incorporate leading technologies. Oxford BioT...

oxbtc.com oxbtc.com

牛比特-OXBTC

oxbtest.com oxbtest.com

TEST CENTER - 영어 테스트 전문. 옥스비어학원

TOEFL / 아카데믹 라이팅 / 개인 레슨] 7월 수업. 주말 집중회화 7월 수강신청 안내]. 소수 정원 TOEFL] 7월 수업 안내. 아카데믹 라이팅 7월 특강 안내]. 아카데믹 라이팅] 7월 수업 공지 안내. 토, 일 주말 집중 영어회화] 6월 개강 안내. 소수정원 토플] 6월 수업 공지. 소수정원 TOEFL] 5월 수업 안내. 토,일 주말집중 영어회화] 5월 개강 안내.

oxbtoeic.com oxbtoeic.com

?щŸщ??˜ 諛⑸Ц?„ ?˜??⑸‹ˆ??

oxbu.com oxbu.com

domain for sale